Patents by Inventor Kenneth C. Fang

Kenneth C. Fang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions, methods and kits for diagnosis of lung cancer
    Patent number: 11913957
    Abstract: Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: February 27, 2024
    Assignee: Biodesix, Inc.
    Inventors: Paul E. Kearney, Kenneth C. Fang, Xiao-Jun Li, Clive Hayward, Douglas Spicer
  • COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
    Publication number: 20220170938
    Abstract: Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).
    Type: Application
    Filed: September 9, 2021
    Publication date: June 2, 2022
    Inventors: Paul E. Kearney, Kenneth C. Fang, Xiao-Jun Li, Clive Hayward, Douglas Spicer
  • COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
    Publication number: 20210285950
    Abstract: Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC).
    Type: Application
    Filed: October 13, 2020
    Publication date: September 16, 2021
    Inventors: Paul E. Kearney, Kenneth C. Fang, Xiao-Jun Li, Clive Hayward